TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM
$19.6M
This Quarter Return
-33.23%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$16.2M
AUM Growth
+$16.2M
(-39%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
99.89%
Holding
11
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
HilleVax
HLVX
$105M
| $9.75M | 60.21% | 6,724,000 | – | – |
|
2
Ovid Therapeutics
OVID
$91M
| $2.35M | 14.51% | 7,531,996 | – | – |
|
3
Xilio Therapeutics
XLO
$36.3M
| $1.07M | 6.6% | 1,475,121 | – | – |
|
4
Equillium
EQ
$62.2M
| $712K | 4.4% | 1,824,977 | – | – |
|
5
American Well
AMWL
$111M
| $613K | 3.78% | 77,733 | – | – |
|
6
Shattuck Labs
STTK
$47M
| $490K | 3.02% | 515,619 | – | – |
|
7
Lyell Immunopharma
LYEL
$213M
| $443K | 2.74% | 823,317 | – | – |
|
|
TSBX
8
DELISTED
Turnstone Biologics
TSBX
| $367K | 2.27% | 895,824 | – | – |
|
9
Rani Therapeutics
RANI
$24.4M
| $256K | 1.58% | 203,190 | – | – |
|
|
THRD
10
DELISTED
Third Harmonic Bio
THRD
| $128K | 0.79% | 36,835 | – | – |
|
11
Standard BioTools
LAB
$481M
| $17.8K | 0.11% | 16,515 | – | – |
|